NCT06138483View on ClinicalTrials.gov

A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse

RecruitingOBSERVATIONAL
Enrollment

267

Participants

Timeline

Start Date

April 19, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Oropharyngeal Squamous Cell Carcinoma
Trial Locations (5)

Unknown

RECRUITING

Centro di Riferimento Oncologico (CRO), IRCCS, Aviano

RECRUITING

Ospedale San Martino di Belluno - ULSS 1 Dolomiti, Belluno

RECRUITING

Ospedale dell'Angelo - Mestre - Ulss 3 Serenissima, Mestre

RECRUITING

Ospedale Santa Maria degli Angeli - ASFO, Pordenone

RECRUITING

Ospedale di Treviso - ULSS 2 Marca Trevigiana, Treviso

All Listed Sponsors
lead

Centro di Riferimento Oncologico - Aviano

OTHER